# Ultragenyx Pharmaceutical Inc.: Form 8-K, filed Oct 3, 2024

- Company: [Ultragenyx Pharmaceutical Inc.](/companies/rare.md) (CIK 1515673)
- Form: 8-K
- Filed: 2024-10-03
- Accepted by EDGAR: Oct 3, 2024, 16:34 ET
- Period: 2024-10-03
- Accession: 0000950170-24-112402
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1515673/000095017024112402/rare-20241003.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1515673/000095017024112402/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1515673/000095017024112402/rare-20241003.htm

Filed Oct 3, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-112402. Last ingested by Listed: Oct 30, 2026, 14:15 ET. No prices; not investment advice.